MRSH
US EQUITY
Financials
Insurance Brokers
CIK: 62709
Marsh McLennan (MRSH) Quant Factor Diagnostic & Fair Value Model
Marsh McLennan (Ticker: MRSH) is listed in the Financials sector (Insurance Brokers). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$197.48
-0.90%
Latest Close (2026-10-23)
Market Cap: $94.24B
P/E Ratio: 18.8
Momentum Strength
3M / 12M
+7.73%
1M: +16.21%
12M: +4.32%
Quality (ROE)
Point-in-Time
+13.21%
Trailing Return on Equity
Technical Trend
RSI 14
90.0
SMA50: $181.59
SMA200: $176.92
Valuation Multiplier
Trailing
18.8
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
MRSH trades within a typical sector multiple band (18.8x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 62709 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-07-21 | $7.40B | $1.27B | $835.00M | $2.63 |
| 10-Q | 2025-12-31 | 2026-07-21 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-07-21 | $6.97B | $1.21B | $1.05B | $2.45 |
| 10-Q | 2026-03-31 | 2026-04-16 | $7.60B | $1.15B | -$688.00M | $2.36 |
| 10-Q | 2025-03-31 | 2026-04-16 | $7.06B | $1.38B | -$622.00M | $2.79 |
| 10-K | 2025-12-31 | 2026-02-09 | $26.98B | $4.16B | $5.29B | $8.43 |
| 10-K | 2024-12-31 | 2026-02-09 | $24.46B | $4.06B | $4.30B | $8.18 |
| 10-K | 2023-12-31 | 2026-02-09 | $22.74B | $3.76B | $4.26B | $7.53 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Marsh McLennan (MRSH) valuation multiples, momentum factors, and point-in-time filing conventions.
How should MRSH's current valuation multiple be interpreted? ↓
MRSH trades at a trailing P/E of 18.8x within the Financials sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are MRSH's key momentum and technical factor indicators? ↓
As of the latest close, MRSH shows a 1-month return of +16.21%, 3-month return of +7.73%, and 12-month return of +4.32%, with a 14-day RSI of 90.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for MRSH? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can MRSH be incorporated into systematic factor models? ↓
MRSH can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.